Salwa Abdelbagi Elhassan Musa

Dr. Salwa Abdelbagi Elhassan Musa


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2020 in International Journal of Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
SMSalwa Abdelbagi Elhassan Musa
Salwa Abdelbagi Elhassan Musa
AIAreej A. Ibrahim
Areej A. Ibrahim
SHSamar S. Hassan
Samar S. Hassan
MJMatthew B Johnson
Matthew B Johnson
ABAsmahan T. Basheer
Asmahan T. Basheer
MAMohamed A. Abdullah
Mohamed A. Abdullah
Background: Fanconi-Bickel syndrome (FBS) is a rare condition of carbohydrate metabolism, caused by a recessive defect in the facilitative glucose transporter GLUT2 encoded by theSLC2A2gene and characterized by a wide spectrum of phenotypical features. There is a paucity of reported data on FBS from Sub-Saharan Africa. Here, we describe the clinical, biochemical and genetic characteristics of our patients with FBS from Sudan, a country with a high consanguinity rate.Patients & methods: Eleven patients from ten unrelated Sudanese families were included. Clinical & biochemical data were documented and imaging studies done including bone survey and abdominal ultrasound. Liver biopsy was done to confirm the pathological diagnosis in 45% of cases and molecular genetics was performed through contribution with the Exeter genomics laboratory for ten patients.Results: Reported consanguinity was 70% among our patients. Growth was significantly impaired at presentation with mean weights of (-5.3 ± 1.8) SD and heights (-5.4 ± 2.5) SD. Severe chest deformity was present in (27%) and all patients showed features of rickets at presentation. Three patients had neonatal diabetes requiring insulin therapy of which one has been reported before. Six families lost undiagnosed siblings with similar clinical presentations. We identified a total of four homozygous pathogenicSLC2A2variants in our patients, one of whom had a novel mutation.Conclusions: FBS is not uncommon in Sudan where there is a high rate of consanguinity. Many cases are likely missed because of variable presentation and lack of public and professionals’ awareness. This is the first series to describe this condition from Sub-Saharan Africa.

21 October 2021 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
ARAmanda Rowlands
Amanda Rowlands
ADAsma Deeb
Asma Deeb
Asmahane LadjouzeAsmahane Ladjouze
Asmahane Ladjouze
RHRasha T Hamza
Rasha T Hamza
SMSalwa Abdelbagi Elhassan Musa
Salwa Abdelbagi Elhassan Musa
JCJean-Pierre Chanoine
Jean-Pierre Chanoine
Congenital adrenal hyperplasia (CAH), if untreated, carries high morbidity and mortality. A higher incidence of CAH is expected in countries where consanguinity is common, such as in the countries of the WHO Eastern Mediterranean Region (EMRO). CAH is managed through lifelong treatment with fludrocortisone and hydrocortisone. In this analysis, performed in the 22 EMRO countries and territories plus Algeria, we review which countries offer a neonatal screening programme for CAH and describe the barriers and opportunities to access oral fludrocortisone and oral and injectable hydrocortisone. Neonatal CAH screening was only available nationally in Qatar, Kuwait and partially in Lebanon and Saudi Arabia. We reviewed the national lists of essential medicines (NEMLs) and found that 13/23 (57%) countries included fludrocortisone and 18/23 (78%) included oral hydrocortisone. Fludrocortisone was not included by any of the low-income countries and oral hydrocortisone was only included by one low-income country. We then contacted paediatric endocrinologists in each country to assess perceived availability of these medicines. Overall, there was a relatively good consistency between inclusion of fludrocortisone and hydrocortisone in the NEML and their actual availability in a country. We propose several mechanisms to improve access, including prequalification by the WHO, a common registration process for groups of countries, pooled procurement, working with local pharmaceutical companies, special access status for medicines not yet registered in a country and compounding. We suggest that access to medicines requires a collaboration between health professionals, families of patients, health authorities, pharmaceutical companies and the WHO.

15 February 2024 in Pediatric Diabetes
Verified
Journal Article
Open access
PDF file
SHSamar Sabir Hassan
Samar Sabir Hassan
SMSalwa Abdelbagi Elhassan Musa
Salwa Abdelbagi Elhassan Musa
EFElisa De Franco
Elisa De Franco
RFRussel Donis Frew
Russel Donis Frew
OBOmer Osman Babiker
Omer Osman Babiker
MAMohamed A. Abdullah
Mohamed A. Abdullah
Neonatal diabetes (ND) is a rare subtype of diabetes occurring in the first 6months of life. High incidence has been reported among populations with high rates of consanguineous marriage. However, there is paucity of reported data from sub-Saharan African countries. We report the incidence, genotype, and phenotype of ND in a large cohort from Sudan and compare these findings to regional and international data. All infants with onset of diabetes in the first 6months of life, attending one of the only two tertiary pediatric diabetes centers in Sudan, Gaafar Ibn Auf Pediatric Tertiary Hospital and Sudan Childhood Diabetes Center, during the period of January 2006 to December 2022 were included. Medical records were reviewed for demographic and clinical information. Genetic testing was performed for 48 patients by the Exeter Genomics laboratory in the UK and for one patient by the University of Cambridge, Metabolic Research Laboratories, UK. The estimated incidence was 4.8 per 100,000 live births. Forty-nine ND patients from 45 unrelated families were identified, and a genetic diagnosis was confirmed in 37 patients (75.5) from 33 unrelated families. Consanguinity was reported in 34 families (75.6). The commonest genetic cause for permanent neonatal diabetes was EIF2AK3 recessive variants causing WolcottRallison syndrome (18.92). Pathogenic variants in two recently identified genes, ZNF808 and NARS2, were found in three patients each (8.11). Activating variants in KCNJ11 and ABCC8 were identified in four (10.81) and two (5.41) patients, respectively. Apart from hyperglycemia, the commonest clinical presentations included dehydration, failure to thrive, and diabetic ketoacidosis. ND in Sudan has a different pattern of etiologies compared to Western and Asian populations yet similar to some Arab countries with EIF2AK3 mutations being the commonest cause. Pathogenic variants in recently identified genes reflect the impact of genome sequencing on increasing the rate of genetic diagnosis.

1 October 2021 in Journal of Pediatric Endocrinology and Metabolism
Verified
Journal Article
Closed access
SMSalwa Abdelbagi Elhassan Musa
Salwa Abdelbagi Elhassan Musa
SHSamar Sabir Hassan
Samar Sabir Hassan
AAAmna I. Ahmed
Amna I. Ahmed
TNThomas Ngwiri
Thomas Ngwiri
GFGhassan F. Fadlalbari
Ghassan F. Fadlalbari
MAMohamed A. Abdullah
Mohamed A. Abdullah
Objectives: Primary adrenal insufficiency (PAI) in children is an uncommon condition. Congenital adrenal hyperplasia (CAH) is the commonest cause followed by autoimmune disorders. Diagnosis and management are challenging especially in resource-limited settings. Studies from Africa are scanty and here we describe for the first time the clinical presentation, possible etiologies, and challenges in diagnosis and management of PAI in a large cohort of Sudanese children. Methods: This was a descriptive hospital-based study where all patients diagnosed with PAI between 2006 and 2020 were reviewed. The diagnosis was based on clinical presentation, low morning cortisol ± high adrenocorticotropic hormone (ACTH), or inadequate response of cortisol to synacthen stimulation. Challenges faced in diagnosis and management were identified. Results: From 422 PAI suspected patients, 309 (73.2%) had CAH, and 33 (7.8%) had PAI-like symptoms and were not furtherly discussed. Eighty patients (19%) had fulfilled the study criteria: 29 had Allgrove syndrome, nine auto-immune polyendocrinopathy syndrome, seven adrenoleukodystrophy, and one had an adrenal hemorrhage. Hyperpigmentation was the cardinal feature in 75 (93.8%) while the adrenal crisis was not uncommon. Lack of diagnostic facilities has obscured the etiology in 34 (42.5%) patients. Conclusions: PAI is not uncommon in Sudanese children where genetic causes outweigh the autoimmune ones. Many cases were missed due to nonspecific presentation, lack of awareness, and difficult access to tertiary health care facilities. In addition to the clinical findings, early morning cortisol ± ACTH levels can be used in diagnosis where facilities are limited particularly synacthen stimulation test.

18 December 2024 in Journal of Reproductive and Infant Psychology
Verified
Journal Article
Open access
Agustini UtariAgustini Utari
Agustini Utari
MSMarcelo Silberkasten
Marcelo Silberkasten
SMSalwa Abdelbagi Elhassan Musa
Salwa Abdelbagi Elhassan Musa
SHSamar Sabir Hassan
Samar Sabir Hassan
RSRajni Sharma
Rajni Sharma
SDStenvert L. S. Drop
Stenvert L. S. Drop
Management of Differences of Sex Development (DSD) is complex and in resource limited settings the psychosexual and psychosocial aspects of DSD care have received limited attention. This review aims to explore recent literature on psychosocial care of DSD in low and upper middle-income countries (L/UMIC). Scientific databases were searched and papers on management of DSD were reviewed according to predefined inclusion criteria. Papers published between January 2010 and July 2024 were screened for eligibility. Seventy studies specifically focusing on psychosexual and psychosocial aspects were identified. In these papers, the following aspects were studied in detail: gender identity, sexual behaviour, quality of life, perception of parents and society, communication and family counselling and socio-cultural and religious aspects. The geographical distribution and volume of studies on the psychosexual and psychosocial aspects of DSD in L/UMIC are mostly originating from East-and South-Asia and South & Central America. The findings underscore the need for integrated and culturally sensitive interventions to support the psychosocial well-being of patients and their families affected by DSD within resource-limited contexts. We highly recommend providing specific guidelines recognising the socio-cultural milieu and resource restricted settings. International collaboration providing education and training should be encouraged.

3 March 2025 in European Journal of Endocrinology
Verified
Journal Article
Open access
SMSalwa Abdelbagi Elhassan Musa
Salwa Abdelbagi Elhassan Musa
MAMohamed A Abdullah
Mohamed A Abdullah
SHSamar S Hassan
Samar S Hassan
LFLuqman S Fauzi
Luqman S Fauzi
OBOmer O Babiker
Omer O Babiker
CSChris J Smith
Chris J Smith
Objective: Studies of primary adrenal insufficiency (PAI) in African children are rare, but in Sudan, congenital adrenal hyperplasia (CAH) and triple A syndrome are the most common genetic causes. Differential diagnosis is challenging, especially in resource-limited settings, where presentation can mimic common childhood diseases and facilities for biochemical and genetic testing may be restricted. Design: Forty-eight patients from 43 families (31 male:17 female) with PAI were included (CAH/triple A excluded). Additional features seen included white matter changes on magnetic resonance imaging, auto-immune features, and/or obesity. Sanger and whole exome sequencing (WES) were employed for diagnosis, confirmation, and segregation with in vitro assays to investigate potential splice defects. Results: In 21/43 families, a genetic aetiology consistent with non-autoimmune PAI was discovered, and in 3 families, autoimmune regulator (AIRE) mutations were found, indicating an autoimmune origin. In Sudan, adenosine triphosphate (ATP) binding cassette subfamily D member 1 (ABCD1)/nicotinamide nucleotide transhydrogenase (NNT)/AIRE mutations were commonest, including recurrent NNT splice and AIRE deletion mutations. In 2 families, we identified ARSA mutations fitting a diagnosis of metachromatic leucodystrophy (MLD), in which adrenal insufficiency has not previously been described. In the remaining 17 families, no causative gene mutations were found. Putative causal variants for comorbidities were concomitantly detected. Conclusions: In this population, WES revealed itself as a useful frontline tool for the differential diagnosis of individuals presenting with adrenal insufficiency, including discrimination between MLD and adrenoleucodystrophy and giving plausible gene defects for additional comorbidities such as obesity. Such genetic diagnoses are crucial to design optimal treatment plans and for genetic counselling in affected individuals and their families.